Debra L. Beck, MSc

AMP 2021

N'Dandu: PROMISE II Update on Deep Vein Arterialization With LimFlow

08/13/2021

August 11, 2021 — In a session entitled “Feet Matter. Pedal Arteries Matter,” Zola N’Dandu, MD, Section Head of Cardiology at Ochsner Medical Center-Kenner (Louisiana) presented on best practices and patient identification for deep vein...

August 11, 2021 — In a session...

08/13/2021

Vascular Disease Management

Meeting Exclusive

IN.PACT Global Study: 5-Year Diabetic and Gender Subgroup Outcomes

01/17/2022

Marianne Brodmann , MD;

Debra L. Beck , MSc;

At ISET 2022, Dr. Marianne Brodmann discussed outcomes from the IN.PACT Global Study stratified according to gender and diabetes status.

At ISET 2022, Dr. Marianne...

01/17/2022

Vascular Disease Management

AMP 2021

Mustapha: Taking the ELUVIA DES Technology BTK

08/13/2021

Debra L. Beck , MSc;

Course Director Jihad A. Mustapha, MD, from Advanced Cardiac & Vascular Centers for Amputation Prevention (Grand Rapids, MI) and Michigan State University (East Lansing, MI) presented a talk at AMP 2021 on the the use of the ELUVIA...

Course Director Jihad A....

08/13/2021

Vascular Disease Management

ISET 2022

Final 3-Year VIVO Outcomes: Zilver Vena Venous Stent in Symptomatic Iliofemoral Venous Outflow Obstruction

01/18/2022

Anthony J. Comerota , MD;

Debra L. Beck , MSc;

The real-world safety and effectiveness of the Zilver Vena venous stent for patients with symptomatic iliofemoral venous outflow obstruction were presented at ISET 2022 by Anthony J. Comerota, MD.

The real-world safety and...

01/18/2022

Vascular Disease Management

AMP 2021

Scott: 12-Month Results of the REALITY Study of Directional Atherectomy Alone and With Drug-Coated Balloons

08/13/2021

Debra L. Beck , MSc;

In a session devoted to atherectomy and its use in patients with critical limb ischemia (CLI), Eric C. Scott, MD (The Iowa Clinic, Des Moines, Iowa), shared the 12-month results of the REALITY study of directional atherectomy alone and with...

In a session devoted to...

08/13/2021

Vascular Disease Management

Meeting Exclusive

Three-Year Survival in CLTI Patients with FFR-Guided Revascularization of Silent Coronary Ischemia

01/18/2022

Debra L. Beck , MSc;

Christopher K. Zarins , MD;

Christopher K. Zarins, MD, presented the 3-year findings from his recently published trial on the benefits of coronary computed-tomography derived FFRct in the evaluation of CLTI patients.

Christopher K. Zarins, MD,...

01/18/2022

Vascular Disease Management

AMP 2021

Lichtenberg: MIMICS-3D: Two-Year Clinical Outcomes for the BioMimics 3D Stent

09/22/2021

Debra L. Beck , MSc;

Principal investigator Michael Lichtenberg, MD, presented attendees of AMP 2021 with 2-year data for the MIMICS-3D Trial, which evaluated the BioMimics 3D stent in a real-world population.

Principal investigator Michael...

09/22/2021

Vascular Disease Management

AMP 2021

Adams: Real-World Data From Liberty 360

08/13/2021

Debra L. Beck , MSc;

August 12, 2021 — The Liberty 360 study was a prospective, observational, multicenter study to evaluate the procedural and long-term clinical and economic outcomes of endovascular device interventions in patients across all Rutherford...

August 12, 2021 — The Liberty...

08/13/2021

Vascular Disease Management

AMP 2021

Zeller: The DEEPER OUS Recoil Data

08/13/2021

Debra L. Beck , MSc;

August 12, 2021 — On Day 2 of this year’s hybrid in-person/virtual AMP conference, Thomas Zeller, MD, delivered a short talk on the Temporary Spur stent system (Reflow Medical) and the DEEPER OUS trial. The SPUR stent, developed by Reflow...

August 12, 2021 — On Day 2 of...

08/13/2021

Vascular Disease Management

Meeting Exclusive

DISRUPT PAD III Update: Intravascular Lithotripsy for PAD

07/08/2021

Debra L. Beck , MSc;

Andrew Holden , MBChB;

Written by Debra L. Beck, MSc; Presented by Andrew Holden, MBChB

Written by Debra L. Beck, MSc;...

07/08/2021

Vascular Disease Management